Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Par Drugs & Chemicals Financial Results

Par Drugs and Chemicals Limited approved its FY2026 audited financial results and authorized a ₹90 Crore investment limit. The board also renewed its ₹1.61 Crore banking facility.

Source

NSE filing, NSE: PAR. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Par Drugs & Chemicals Ltd: key numbers

Share price
₹114.96
Market cap
₹141.4 Cr
Revenue (annual)
₹103.7 Cr
Net profit (annual)
₹13.11 Cr
P/E (TTM)
9.8×Sector 46.1×
Promoter holding
73.41%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Par Drugs & Chemicals Ltd

All →

Other financial results announcements

All →